Cytalux (Pafolacianine Injection) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cytalux. Always confirm against the full prescribing information.
6 interactions
5-methyltetrahydrofolic acid
5-methyltetrahydrofolic acid may decrease effectiveness of Pafolacianine as a diagnostic agent.
Level 1 evidence
Folic acid
Folic acid may decrease effectiveness of Pafolacianine as a diagnostic agent.
Level 1 evidence
Leucovorin
Leucovorin may decrease effectiveness of Pafolacianine as a diagnostic agent.
Level 1 evidence
Levoleucovorin
Levoleucovorin may decrease effectiveness of Pafolacianine as a diagnostic agent.
Level 1 evidence
Levomefolic acid
Levomefolic acid may decrease effectiveness of Pafolacianine as a diagnostic agent.
Level 1 evidence
Glucarpidase
The serum concentration of the active metabolites of Pafolacianine can be reduced when Pafolacianine is used in combination with Glucarpidase resulting in a loss in efficacy.
Cytalux (Pafolacianine Injection) has 6 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Cytalux (Pafolacianine Injection) has 0 major, 5 moderate, and 1 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cytalux. Always confirm against the full prescribing information.